Oncology Information System (OIS) Market Insights Reveal Increasing Investment in Personalized Cancer Care

The global Oncology Information System (OIS) market is poised for robust growth, expected to more than double from a valuation of US$ 3.3 billion in 2024 to US$ 7.1 billion by 2035, according to a new market research report. Growing at a healthy compound annual growth rate (CAGR) of 7.2% between 2025 and 2035, the market is driven by the increasing global burden of cancer and the critical need for streamlined data management across oncology care domains.

The rising incidence of cancer worldwide—nearly 20 million new cases and close to 10 million deaths recorded in 2022 alone—is placing unprecedented pressure on healthcare providers to deliver timely, accurate, and personalized oncology care. Oncology Information Systems are emerging as indispensable tools that unify patient data, automate treatment planning, and facilitate real-time monitoring in medical, radiation, and surgical oncology.

Advancements in AI, Cloud Platforms, and Interoperability Transform Market Landscape
The shift towards precision oncology and AI-driven treatments is accelerating demand for sophisticated OIS platforms capable of integrating molecular profiling, genomic data, and predictive analytics. Cloud-based delivery models enhance scalability and remote access, while interoperability with electronic health records (EHR) and imaging systems is becoming a standard feature, enabling multidisciplinary care coordination.

North America leads the global market, supported by advanced healthcare IT infrastructure, government-backed precision medicine initiatives, and high adoption rates of digital oncology platforms. The U.S., in particular, is home to numerous National Cancer Institute-designated cancer centers utilizing AI-enabled OIS to improve treatment planning and patient surveillance.

Meanwhile, the Asia Pacific region is witnessing rapid market expansion fueled by healthcare digitization investments and rising cancer prevalence. Europe remains committed to integrating automation and combined care models in oncology, with key players like Elekta, Varian (Siemens Healthineers), and Cerner spearheading innovation through AI and strategic partnerships.

Software Solutions Dominate, Enabling Multidisciplinary Care and Enhanced Outcomes
Software solutions, including patient information systems and treatment planning systems, dominate the OIS market due to their pivotal role in managing complex oncology workflows. Platforms such as Elekta’s MOSAIQ offer unified environments that enhance clinical coordination and improve patient outcomes by centralizing treatment data and analytics.

Key Industry Players Drive Innovation and Strategic Collaborations
Market leaders—including Varian Medical Systems, Elekta, Philips Healthcare, Cerner, Epic Systems, Siemens Healthineers, and others—are actively investing in technological advancements and strategic partnerships to expand their oncology solution portfolios. Notable recent developments include Siemens Healthineers’ acquisition of Varian Medical Systems in 2021 and Philips’ collaboration with Elekta to enhance precision oncology care.

Oncology Information System Market Snapshot:

Market Size (2024): US$ 3.3 billion

 

Forecast Size (2035): US$ 7.1 billion

 

CAGR (2025-2035): 7.2%

 

Key Segments: Software (Patient Information Systems, Treatment Planning Systems), Services

 

Applications: Medical Oncology, Radiation Oncology, Surgical Oncology

 

Leading Region: North America, followed by Asia Pacific and Europe

Visit our report to explore the detailed insights and key takeaways –

https://www.transparencymarketresearch.com/oncology-information-system-market.html